Schema therapy for Anorexia Nervosa
- Conditions
- eating disorderfeeding disorder10014067
- Registration Number
- NL-OMON53672
- Lead Sponsor
- Parnassia Groep.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 12
- A DSM-5 diagnosis anorexia nervosa
- Age between 16-65 years
- BMI >= 15 and somatically stabile as is defined in the department*s crisis
protocol and evaluated by a physician specialised in eating disorders.
- Patients in an acute state of mental crisis who need immediate
hospitalization or treatment for high suicide risk
- Patients with intellectual disability
- Patients who cannot complete the questionnaires because of insufficient
language skills, practical or cognitive limitations
- Not willing (or being able) to sign the informed consent form of this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>This study investigates the effects of a thirty week schema therapy in reducing<br /><br>eating disorder symptoms of patients with anorexia nervosa.<br /><br>Hypothesis:<br /><br>Based on previous research (McIntosh et al., 2016; Pauwels, Dierckx,<br /><br>Schoevaerts, & Claes, 2016; Pugh, 2015; Simpson et al., 2010; Waller, Dickson,<br /><br>& Ohanian, 2002) it is expected that schema therapy will improve eating<br /><br>disorder symptoms for patients with anorexia nervosa. </p><br>
- Secondary Outcome Measures
Name Time Method <p>This study seeks to examine the changing nature of schema*s and modes in<br /><br>patients with anorexia nervosa during schema therapy.<br /><br>Hypothesis: It is expected to demonstrate a reduction in schema*s and modes for<br /><br>patients with anorexia nervosa during schema therapy. </p><br>